Purpose: Risk factors and consequences of asthma can be studied by using validated questionnaires. The overall objective of this study was to assess the agreement of parental-reported asthma-related questions regarding their children against Swedish health care registers.
| INTRODUCTION
To study risk factors and consequences of asthma, validated instruments for defining asthma in studies using registers, clinical cohorts, and questionnaires are needed. Numerous efforts have been made to ensure that specific questionnaires detecting asthma are standardized, repeatable, and can be applied consistently across a range of geographical and cultural settings. 1, 2 Both the European Community Respiratory Health Survey 1 and the International Study on Asthma and Allergies in Childhood (ISAAC) 2 were developed, where possible, from preexisting published questionnaires, where validity had been previously assessed. 3, 4 Several studies have validated questions on "reported ever asthma" [5] [6] [7] and symptom-based outcomes (eg, wheeze, waking at night, and coughing), [8] [9] [10] [11] whereas others have focused on doctor's diagnosis 6 or taking asthma medication. 6 Other examples of asthma validation studies include symptom-based questions against clinical evaluations, 5,8 structured interviews, 12 and patient records of a diagnosis. 13 The standardized ISAAC questionnaire 2 has a specific question on "reported ever asthma" for which validity in other countries has been assessed 5, 7 but not in Sweden. In addition, to our knowledge, no study has assessed the validity of the questions describing "reported current asthma" and doctor's diagnosis from the ISAAC questionnaire. Furthermore, timing of dispenses has been investigated in a previous study in which agreement between reported and prescribed asthma medication was highest within an 18-month window. 14 Questionnaire studies are relatively low cost, time-efficient, and permit large sample sizes compared with clinical data collections. 15, 16 On the other hand, questionnaires are often restricted to specific age groups or specific areas, which can reduce generalizability to other populations. 17, 18 Identifying affected individuals often involves retrospective questioning about doctor's diagnosis and previous symptoms, therefore subject to recall bias. 19, 20 By using populationbased register data for asthma diagnoses and prescriptions, the data are objective and some of the aforementioned errors can be avoided particularly if the coverage of the register is high.
The overall objective for this study was to assess the agreement and Stockholm regional health care data warehouse, VAL, which holds all primary care diagnoses from Stockholm county). Our first aim was to assess the agreement between "reported ever asthma" and a "register-based ever asthma" algorithm 21 (at least 2 dispenses of asthma medication or an asthma diagnosis) using SPDR and NPR and between "reported doctor's diagnosis" and "register-based doctor's diagnosis" from NPR and VAL. Our second aim was to assess the agreement between "reported asthma medications" and "registerbased asthma medications," with the corresponding data within different time windows in the registers. 
| Study design and data sources
This is an agreement study comparing parental interview answers with data from registers where no measure was considered gold standard. 23 Several national health care registers are held by the Swedish National Board of Health and Welfare such as the SPDR 24 and NPR. 25 The SPDR contains the Anatomical Therapeutic Chemical 
| Measures of ever and current asthma in the National cohort
We defined a "reported ever asthma" case as a child with a positive answer to the question "Does he/she have, or has he/she had asthma?" Everyone that replied positive was then directed to other asthma-related questions (see Figure 1 ). "Reported current asthma"
was then defined as reporting positively to the question "Does he/ she still have asthma?"
The "register-based ever asthma" algorithm based on SPDR and NPR data has been previously described and validated. 21 The age-spe- 
KEY POINTS
• Parental-reported question on asthma ever can function as a proxy for asthma medication and diagnosis in research.
• Parental-reported current asthma has good agreement with register-based records in the last 18 months. J45 and J46) from NPR.
To define "register-based current asthma" from the SPDR, we used the same register-based algorithm as for "register-based ever asthma" 21 in combination with conditions placed on recent time windows for asthma diagnosis (ICD-10 diagnostic codes: J45 and J46)
from NPR respectively in the last 6, 12, 18, and 24 months prior to the date of the interview. Instead of a recent diagnosis, we also conditioned on at least 1 dispensed medication (ICS, LTRA, B2, and β2-ICS) from the SPDR. We wanted to investigate several time windows to see which one captured the "reported current asthma" question best and to evaluate if it would be enough using only dispensed medication.
| Measures of a doctor's diagnosis in the Stockholm cohort
A parental-"reported doctor's diagnosis" was defined as answering "yes" to the asthma gated question ("reported ever asthma") plus answering "yes" to "You said that he/she has or has had asthma, has he/she been given that diagnosis by a doctor or nurse?" "Register-based doctor's diagnosis" was defined based on at least 1 primary or secondary diagnosis of asthma up until the time of the interview by ICD-10 codes (J45 and J46) from NPR (inpatient or outpatient) or VAL (primary care).
| Measures of asthma medications in the National cohort
Parental-"reported asthma medications" was defined as answering "yes" to the asthma gated question plus answering "yes" to the following question: "Does your child currently take any asthmamedication (inhalator, spray or tablets)?" This question was added in 2010 as an update to the original questionnaire, so not included for everyone (n = 9860).
"Register-based asthma medications" was defined as at least 1 dispensed asthma medication (ICS, LTRA, β2, and β2-ICS) from SPDR during the last, 6, 12, 18, and 24 months prior to the interview.
| Statistical analyses
Agreement between register data and questionnaire data was assessed, using Cohen's kappa statistic, with 95% CI. The percentage of overall agreement was also estimated. Cohen's kappa is a measure
of agreement beyond what would be expected by pure randomness.
A kappa over 0.75 is characterized as excellent, a kappa of 0.40 to 0.75 is considered fair to good, and 0.40 and below as poor. 27 Statistical Analysis Software 9.4 (SAS Institute, Cary, North Carolina) was used for all analyses.
3 | RESULTS Table 1 lists the demographic characteristics of the subcohorts of the CATSS study: the National and Stockholm cohorts. In general, the characteristics of the smaller Stockholm cohort were very similar to the much larger National cohort. The prevalence of "reported ever asthma" was slightly higher in the Stockholm cohort (17.4%), compared with the national cohort (14.5%). However, "reported current asthma" (7.1%) did not differ substantially between cohorts.
| "Reported ever asthma"
The kappa statistic of "reported ever asthma" and "register-based ever asthma" was 0.69, indicating good agreement. The overall agreement was 92.1% (Table 2) .
| Doctor's diagnosis
The comparison between the parental "reported doctor's diagnosis"
and the "register-based doctor's diagnosis" from NPR or VAL showed a kappa of 0.57, indicating a fair to good agreement. The overall agreement was 86.3% (Table 2 ).
3.3 | "Current asthma" Table 3 shows the agreement between "reported current asthma" and "register-based current asthma" with time-specific criteria for at least 1 dispensed medication or diagnosis within 4 different time windows. 
| DISCUSSION
We found good agreement between "reported ever asthma" and "register-based ever asthma" (kappa = 0.69) and fair to good agreement (kappa = 0.57) between parental-"reported doctor's diagnosis" and "register-based asthma diagnosis." We also found good agreement (kappa = 0.70) between "reported current asthma" and "register-based current asthma," conditional on at least 1 dispensed medication or a diagnosis within the last 18 months. Finally, we found the best g Stockholm regional health care data warehouse (VAL).
h Longitudinal integration database for health insurance and labor market studies (LISA) at the year when children were 5 years.
agreement between "reported asthma medications" by parents and "register-based asthma medications" within the last 18 months (kappa = 0.59).
Previous and similar studies that assessed the validity of the question on "reported ever asthma" against a clinical diagnosis found high sensitivity (ie, proportion with a diagnosis that is correctly identified as such), 0.87 in 1 study, 7 and good sensitivity, 0.68, in another one. 28 Valle et al 7 used a younger cohort than ours, 6 to 7 years old children, and they used a golden standard (ie, clinical diagnosis), which could potentially explain why they found a high estimate of sensitivity (0.87) . Marco et al 28 investigated adults and found good validity (sensitivity of 0.68) while we studied children and found good agreement (kappa = 0.69). In addition, among university students, the question on "reported ever asthma" was validated against a variable combining physician's interview, methacholine challenge, skin prick test, and specific IgE, which reported a low sensitivity (0.40) and a good PPV (0.76). 5 Thus, large heterogeneity in sensitivity, PPV, and Kappa exists between the different studies (age groups and Asthma medication of ≥2 dispenses of inhaled corticosteroid (ICS) and/or leukotriene receptor agonist and/or B2-ICS independent of time between and/ or ≥ 3 dispenses of ICS and/or LTRA and/or B2-ICS and/or B2 within a 12-month period (prior to the date of the interview.
comparison variables) when assessing the validity of "reported ever asthma" from a questionnaire.
We have previously validated the register-based comparison variable "register-based ever asthma" against medical records with high positive predictive values (0.89 95% CI: 0.85-0.92) for clinical asthma diagnosis. 21 This definition of asthma has been applied in several studies as a proxy for ever/incident asthma [29] [30] [31] [32] [33] as well as for current/prevalent asthma. 30 Another study investigating "reported doctor's diagnosis" found a moderate PPV of 0.57 when the question of parental-reported doctor's diagnosis was validated against asthma medication reimbursement in a younger cohort. 6 The question of doctor's diagnosis has also been validated against a structured interview among 7 to 8 years old, which found excellent PPV (0.98) and good sensitivity (approximately 0.70). 12 There are many reasons to our fairly low kappa estimate; for example, asthma diagnosis in low ages is fairly unspecific and those who answered no to the question on "reported ever asthma" never got the question on doctor's diagnosis (see Figure 1 ). In addition, the kappa could be due to both overreporting (the register may not have coverage) and underreporting since a diagnosis given a long time ago may be forgotten if the child has no current asthma symptoms or medication. However, this does not imply per se that our comparison variable is poor.
We estimated the agreement between "reported current asthma"
and "register-based current asthma" with different time windows. We found the 18-month window to be preferable with a kappa of 0.70, which indicates a good agreement. Interestingly, when only using medication data, the resulting kappa just decreased slightly giving us confidence that our "register-based current asthma" including 1 recently dispensed medication is almost as good a proxy for "reported current asthma" as when using both medication and diagnosis. Recall bias has shown not to be influential within the last 12 months in a recent study of self-reported hospital admissions compared with administrative records. 34 In light of this, it is not surprising that reported "current" asthma (with no time frames in the question) equals "in the last 18 months." Possible explanations could be purchasing large amounts of medicines irregularly, having mild asthma which does not require medications or sharing medicines with other family members. 14 We were unable to find any other studies that had assessed the validity of "reported current asthma." Current wheeze is more common to validate in childhood than current asthma; for example, current wheeze (or wheezing symptoms within the last 12 months) is included in the ISAAC questionnaire and applied in other validation studies. 6, 7 However, wheeze is a symptom and asthma is a condition/disease and children with wheeze do not necessarily need to have asthma. Therefore, those studies using "current wheeze" are limited in generalizing their findings to asthma.
We found a fair agreement between "reported asthma medica- 12 months) and differences in prevalence compared with our study, which affects the kappa. We rather chose to estimate agreement between the answers and register-based information on dispensed medications within 4 different time frames, and we found 18 months to have the best agreement. Importantly, the same time window of 18 months was found preferable in a previous study on the concordance between register data on dispensed drugs and parental-reported use of asthma drugs in adolescents. 14 If all patients had complied with the prescribed treatment, we would probably have an even better register-based measure of asthma, which would be more in agreement with the questionnaire information on whether the child have asthma or not.
Strengths and limitations
The CATSS study has nationwide coverage and high response rate, which strengthen the generalizability of the findings and decrease possible selection bias. Another strength is that data are retrieved from the Swedish health care registers. Register data enable us to obtain an objective measure based on dispensed medication from the SPDR and diagnoses from the NPR. In addition, in Stockholm County, primary health care centers have reported all diagnostic information (ICD- itation is the smaller sample size for "reported asthma medications," as this question was added to the interviews in year 2010. In addition, young children with wheeze and shortness of breath might not always end up with an asthma diagnose by a doctor; therefore, there may be some under-representation in the parental-reported "ever asthma."
We were not able to capture those children and their symptoms in the current study. Furthermore, although a binary measure of asthma is very common in registers and questionnaire based-studies, we recognize that a binary outcome does not accurately represent the heterogeneity of asthma phenotypes and persistence. However, since register-based outcomes for asthma are used widely in the Nordic countries and other countries such as Canada, United States, and Korea, we felt that it was important to test the agreements of commonly used binary outcomes. Registers have the advantages of being cost-effective and are population-based therefore improving generalizability and statistical power. In-depth questionnaire-based cohort studies can provide more information on the various asthma phenotypes important for clinical applications but can suffer from recall-bias and are often smaller hence providing less power for epidemiological questions, and may be less generalizable.
| CONCLUSIONS
We found that parent-reported asthma-related questions showed on average good agreement with the Swedish health care registers, which can be applied for health care research purposes. Valid screening instruments such as questionnaires, registers, clinical cohorts, and patient charts can improve epidemiological research to address various questions on risk factors and consequences of asthma.
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